§ PHARMACEUTICALS
USD · PharmaceuticalsLGND
LIGAND PHARMACEUTICALS
USDSector · PharmaceuticalsBeta · 1.59
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
249 increased/new, 120 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/E | 32.0 | P/B | 3.66 |
| EPS (TTM) | 5.88 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BlackRock, Inc. | 3.0M | 0.0% | +1% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.1M | n/a | n/a |
| JANUS HENDERSON GROUP PLC | 1.0M | n/a | +1% |
| VANGUARD CAPITAL MANAGEMENT LLC | 848K | n/a | n/a |
| State Street | 779K | 0.0% | +4% |
| Fidelity Management | 596K | 0.0% | +3% |
◇ AC INTELLIGENCE
Top institutional owners for LGND as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER44.3% · 256 holders
QUALITY / COMPOUNDER28.1% · 24 holders
PASSIVE / INDEX24.0% · 10 holders
DEALER / BANK14.3% · 33 holders
INCOME / DEFENSIVE2.5% · 24 holders
ACTIVIST0.4% · 1 holder
SYSTEMATIC / QUANT0.2% · 6 holders
TACTICAL / MACRO0.2% · 2 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for LGND in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention LGND yet.